Financial news

General news

• July 2005
  Tremplin Enterprises 2005

  Tremplin Entreprise 2005 laureate

  
  [read more]

• March 2004 : a new corporate agreement

  
  [read more]

• January 2004 : A new article in Journal of Biological Chemistry
  

  Reference : J Biol Chem. 2004 Jan 2;279(1):509-516. Epub 2003 Oct 09.
  abstract of this article online www.jbc.org 
  article
  related articles
  

   
  [read more]

• May 2003 : GGMM Congress

  Two posters have been presented at the GGMM congress :
  TenofovirPoster-GGMM2003.pdf and lopinavir.pdf
  
  
  [read more]

• December 2002 : new agreement

  
  [read more]

• November 2002 : DAART 2002

  
  [read more]

• July 2002 : Discovery of a potent HCV NS3 protease inhibitor

   
  [read more]

• February 2002 : F.A.Q

  Question : The most important aspect is the obtained result. In other words, did the rational drug design work, by indeed delivering active compounds. What is your timeline for synthesis and testing in primary hepatocyte cultures. Does Genoscience have access to in vitro protease inhibition testing? This would be a logical first step before going to hepatocyte cultures. [...]
  
  [read more]

• October 2001

  Scientific validation in progress, with major scientics and institutions.
  [read more]